Velvet CARE has decided to invest in a third Valmet Advantage DCT tissue line for its mill in Osada Klucze, Poland. The order includes an extensive automation package, a control valve package, and Industrial Internet solutions. The target is to meet consumers’ increasing demand for high-quality tissue products with low environmental impact. The value of the order will not be disclosed.
Valmet’s scope of supply comprises an Advantage DCT 200 tissue machine equipped with an OptiFlo headbox and a Yankee cylinder. The line will also feature Advantage tissue technology, including a ViscoNip press, an AirCap Advantage hood with an air system, WetDust systems, and a SoftReel reel.
Valmet will also deliver detailed mill engineering, full stock preparation equipment, a manual pulper feed system, and an automation package, including a Valmet DNA Distributed Control System (DCS) with built-in machine condition monitoring and a Valmet IQ Quality Control System (QCS). The delivery will include a control valve package with valve automation solutions. Valmet Tissue Performance Center services are also part of the scope.
The new tissue line will have a design speed of 2,200 m/min, a width of 5.6 meters, and an annual production capacity of 70,000 tons. It is optimized to save energy and deliver excellent paper properties.
Velvet CARE is one of the largest and most modern producers of paper hygiene products in Poland and Central Europe. Velvet CARE's current annual capacity is up to 150,000 tonnes, with products sold in approximately 30 countries.
Valmet is a leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries.
